cdna-and-odna-microchips-market

cDNA And oDNA Microchips Market By Application (Gene Identification & Detection, Comparative Genomic Hybridization, Gene Expression Profiling, Drug Discovery, Others), By End User (Research Organizations And Institutes, Biotech Companies, Clinical Laboratories) - Growth, Future Prospects & Competitive Analysis, 2021 – 2029

14 Nov 2018 Format PDF icon PPT icon XLS icon Request Sample

"New technology assessment in the cDNA and oDNA microchips market to exhibit noteworthy growth during the forecast period"

The global cDNA and oDNA microchips market is growing effectively, was valued at US$ 547.2 Mn in 2020 and expected to reach US$ 1254.0 Mn by 2029. The global market is growing productively at a CAGR of 9.7% during the forecast period. Incorporation of new technologies in the biological and electronic component of microchips is enhancing the overall growth globally. Advancement in nanotechnology, clinical diagnostics, cancer research, and agriculture also reflects favorable growth during the forecast period. High global prevalence of cancer provides major opportunity in the global market. Increasing popularity of cDNA and oDNA microchips has encouraged many international players to enter the marketplace and gain profit from its growing demand on a global scale, especially in countries such as U.S., Germany, Israel, China, India, Singapore, Japan, and South Korea. DNA microarray market in these countries are poised for enormous growth as drug discovery, biotech & cancer research and clinical trials intensify the overall growth on a global scale.

Rising adoption of biochips for personalized medicine, growing applications in cancer, and technological assessments in advanced DNA microarray systems and sensors are the major drivers of the cDNA and oDNA microchips market. Additionally, the advanced technology in gene chips has now become very popular in the medical research sector and drug discovery, as it considerably brings down the overall research time with enhanced and quick results. This particular technology is mainly used to simultaneously quantify expression levels of thousands of genes. However, outsourcing of bio-processing activities of pharmaceutical and biotechnology companies, strict regulations, high instrumentation expenses in the developing markets may hinder the market development to a certain extent during the forecast period.

cDNA And oDNA Microchips Market

"Gene expression application is expected to register higher growth by the end of 2029"

In 2020, gene expression and profiling in the application segment held the maximum revenue share. The penetration of this segment is high due to its sophisticated stability, low limits of gene detection and wide response range. The advanced product lines play highly complementary roles in genomics, molecular biology, and life science research.

In addition to genetic applications, DNA microarray is also utilized in toxicological, protein, and biochemical research in developed countries. The manufacturers are expanding the usage with higher technology assessment utilized for top applications such as cancer diagnosis, microbial genotyping, genomics, agricultural biotechnology, drug discovery, single nucleotide polymorphism (SNP) analysis and other applications including environmental biology, screening and monitoring of patient data in clinical trials, proteomics, and toxicogenomics. For example, Toyo Seikan Group Holdings (Japan) developing chips designed for definite applications. They have recently developed a DNA chip for examining fungi. The DNA chip distributes more than 630 species of fungi into 32 groups and can test them instantaneously.

"Research Organizations and Institutes to dominate the market with a significant CAGR"

Growth & development of the cDNA and oDNA microchips in research organizations along with biotech firms will gain traction during the forecast period. cDNA and oDNA microchips are now considered as an important tool for biomarker discovery, cancer research molecular cytogenetics, agricultural biotechnology and genomics. The rise in usage of genome testing is generating significant revenue share globally. A notable growth in the drug discovery applications, gene identification & detection show promising opportunities in the near future.

Additionally, administrations of cDNA and oDNA microchips as biochips, lab on chip, clinical proteomics and advanced usage for cancer diagnostics show significant growth in the market. The global market is largely driven by development in personalized medicine, need for early cancer detection and government or private funding in developing nations for advanced research.

"Increasing applications along with swift new technology launch, and presence of top players holds North America in dominant position"

Presently, the U.S generated maximum market share in the global cDNA and oDNA microchips market attributed to the increasing adoption of DNA microarrays and progression in the field of biotechnology, microelectronics, and nanotechnology. The North America cDNA and oDNA microchips market is driven by the applications in drug discovery & development, higher preference for compact DNA microarrays, shift towards the use of live model systems for gene identification and evaluation, and growing demand for advanced research in cancer and diagnostics industry.

Key factors funding to the overall growth include rising R&D in the gene expression profiling segment, increasing adoption of personalized medicine and the development of miniaturized analytical equipment or chips on a global scale. Additionally, it is projected that the biochips market in the Asia Pacific and Europe will witness rapid growth in the given period of forecast. The increase in biopharmaceutical companies from the Asia Pacific, especially in countries such as China, South Korea, and India coupled with the recent trend of outsourcing of research processes to Asian countries for various genome applications would drive the market.

"Presence of multinational manufacturers with strong technology portfolio in the developed regions"

Top manufacturers in the cDNA and oDNA microchips market are Sequenom, Inc., GE Healthcare, Thermo Fisher Scientific, Roche Nimblegen, Biometrix Technology, Cepheid, Agilent Technologies, Inc., Applied Microarrays, Inc., DNA Chip Research, Inc., DNAmicroarray, Inc., Greiner Bio-One GmbH, Illumina, Inc., Scienion AG, Life Technologies Corporation, Toray International UK Ltd., Affymetrix, Inc., and others.

Major corporations are implementing advanced approaches along with new technology assessments in new DNA microarray models in drug discovery, medical diagnostics, and advance biotech research. For instance, in June 2020, CellChipGroup at the Vienna University of Technology developed the miniaturized wound healing system (a chip for wound healing measurement). Additionally, in September 2020, GSI Lumonics, Inc. and NEN Life Science Products signed an agreement to jointly market laser scanner systems and DNA microarray systems globally.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of cDNA And oDNA Microchips market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the cDNA And oDNA Microchips market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Application
  • Gene Identification & Detection
  • Comparative Genomic Hybridization
  • Gene Expression Profiling
  • Drug Discovery
  • Others (Re-sequencing/Genomics, Molecular Cytogenetics, Proteomics, Agricultural Biotechnology)

End User
  • Research Organizations and Institutes
  • Biotech Companies
  • Clinical Laboratories

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of cDNA And oDNA Microchips market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the cDNA And oDNA Microchips market?
  • Which is the largest regional market for cDNA And oDNA Microchips market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving cDNA And oDNA Microchips market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the cDNA And oDNA Microchips market worldwide?
Choose Licence Type
$4325
$6325
$12650
Why Acute
View Other Reports